Association of Women Authors With Women Enrollment in Clinical Trials of Atrial Fibrillation

Temporal Trends of Enrollment by Sex and Race in Major Cardiovascular Randomized Clinical Trials

“…Our results also confirm that the level of diversity among patients is underrepresented and that a paucity of data exists on diverse enrollment in CV trials. 3 , 30 , 32 , 33 Although our study did not assess temporality of trial leadership, one similar study noted that the proportion of women-led atrial fibrillation trials has not improved significantly from 1985 to 2019, 34 and this factor should be assessed across all CV indications to see if this association is pervasive throughout cardiology. Allana et al.…”

Sex differences in the outcomes after transcatheter aortic valve replacement with newer generation devices: A meta‐analysis

“…It is critical to understand that increasing the presence of women investigators and leaders in clinical trials can have a positive impact and lead to greater female enrollment in clinical trials. 30 Furthermore, women and men may experience different symptoms, comorbidities, and response to therapies. Thus, it is important to ensure that cutting-edge technology is available and being studied effectively in all patients, regardless of their sex, by increasing the number of women in TAVR trials.…”

“…Trial investigators may increase the number of women participating in their trials by directing recruitment efforts toward women or expanding the scope of the eligibility requirements. It is critical to understand that increasing the presence of women investigators and leaders in clinical trials can have a positive impact and lead to greater female enrollment in clinical trials 30 . Furthermore, women and men may experience different symptoms, comorbidities, and response to therapies.…”

Effect of gender on atrial fibrillation ablation outcomes using a propensity score–matched analysis

“…Recent studies have shown an association of women authors with greater enrollment of women in clinical trials for AF. 24 Therefore, women should hold prominent positions in clinical trial leadership in future AF studies. Further exploration of factors that may positively influence the enrollment of women in AF trials also should be investigated.…”